These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38898983)

  • 1. Understanding host immune responses in
    Wang L; Villafuerte Gálvez JA; Lee C; Wu S; Kelly CP; Chen X; Cao Y
    Imeta; 2024 Jun; 3(3):e200. PubMed ID: 38898983
    [No Abstract]   [Full Text] [Related]  

  • 2. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.
    Sun X; Hirota SA
    Mol Immunol; 2015 Feb; 63(2):193-202. PubMed ID: 25242213
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Spigaglia P
    Pathogens; 2024 Jul; 13(8):. PubMed ID: 39204246
    [No Abstract]   [Full Text] [Related]  

  • 4. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
    Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
    mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating gut microbiome and host immune markers to understand the pathogenesis of
    Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Granata G; Schiavone F; Taglietti F; Petrosillo N
    J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568399
    [No Abstract]   [Full Text] [Related]  

  • 7. Host Immune Responses to
    Nibbering B; Gerding DN; Kuijper EJ; Zwittink RD; Smits WK
    Front Microbiol; 2021; 12():804949. PubMed ID: 34992590
    [No Abstract]   [Full Text] [Related]  

  • 8. Host Immune Responses to
    Alam MZ; Markantonis JE; Fallon JT
    Trop Med Infect Dis; 2023 Nov; 8(12):. PubMed ID: 38133438
    [No Abstract]   [Full Text] [Related]  

  • 9. The microbial metabolite urolithin A reduces
    Ghosh S; Erickson D; Chua MJ; Collins J; Jala VR
    mSystems; 2024 Feb; 9(2):e0125523. PubMed ID: 38193707
    [No Abstract]   [Full Text] [Related]  

  • 10. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
    Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
    mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omics investigation of
    Fishbein SR; Robinson JI; Hink T; Reske KA; Newcomer EP; Burnham CD; Henderson JP; Dubberke ER; Dantas G
    Elife; 2022 Jan; 11():. PubMed ID: 35083969
    [No Abstract]   [Full Text] [Related]  

  • 12.
    Schäffler H; Breitrück A
    Front Microbiol; 2018; 9():646. PubMed ID: 29692762
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the gut microbiome in colonization resistance and recurrent
    Seekatz AM; Safdar N; Khanna S
    Therap Adv Gastroenterol; 2022; 15():17562848221134396. PubMed ID: 36425405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.
    Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM
    Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
    mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial ecology between
    Kamiya S
    Biosci Microbiota Food Health; 2023; 42(4):229-235. PubMed ID: 37791342
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection.
    Peritore-Galve FC; Shupe JA; Cave RJ; Childress KO; Washington MK; Kuehne SA; Lacy DB
    PLoS Pathog; 2022 Feb; 18(2):e1010323. PubMed ID: 35176123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation.
    Lopez CA; Beavers WN; Weiss A; Knippel RJ; Zackular JP; Chazin W; Skaar EP
    mBio; 2019 Nov; 10(6):. PubMed ID: 31744916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.